| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/08/2002 | WO2002060470A1 Pyk2 phosphorylation by her3 induces tumor invasion |
| 08/08/2002 | WO2002060469A1 Anticancer agents |
| 08/08/2002 | WO2002060457A1 Anti-stress agents |
| 08/08/2002 | WO2002060451A1 Method of treating certain eye diseases |
| 08/08/2002 | WO2002060450A1 Pyrimidine compounds and methods for making and using the same |
| 08/08/2002 | WO2002060447A1 Receptor selective cannabimimetic aminoalkylindoles |
| 08/08/2002 | WO2002060446A1 Medicinal preparation containing 5-methyl-1-phenyl-2-(1h)-pyridone as active ingredient |
| 08/08/2002 | WO2002060445A1 Kappa opioid receptor ligands |
| 08/08/2002 | WO2002060444A1 Muscarinic receptor agonists |
| 08/08/2002 | WO2002060439A1 Analgesic and antiinflammatory drugs |
| 08/08/2002 | WO2002060438A1 Substituted indoles and their use as integrin antagonists |
| 08/08/2002 | WO2002060437A1 Pharmaceutical compositions including sampatrilat dispersed in a lipoidic vehicle |
| 08/08/2002 | WO2002060436A2 Use of fredericamycin a and its derivatives in the treatment of pin1-associated states |
| 08/08/2002 | WO2002060435A1 Cryptotanshinone for preventing and alleviating alzheimer's disease |
| 08/08/2002 | WO2002060429A1 Preservation of body protein |
| 08/08/2002 | WO2002060421A2 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence |
| 08/08/2002 | WO2002060396A2 Hair follicle neogenesis by injection of follicle progenitor cells |
| 08/08/2002 | WO2002060388A2 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 08/08/2002 | WO2002060386A2 METHODS OF TREATING INFLAMMATORY AND IMMUNE DISEASES USING INHIBITORS OF IλB KINASE (IKK) |
| 08/08/2002 | WO2002060382A2 Novel compounds and uses thereof |
| 08/08/2002 | WO2002060378A2 Substituted aryl compounds as cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 08/08/2002 | WO2002060340A2 Method for identifying maxi-k channel blockers |
| 08/08/2002 | WO2002060339A2 Ophthalmic compositions for treating ocular hypertension |
| 08/08/2002 | WO2002060272A1 Anticholesterolemic edible oil |
| 08/08/2002 | WO2002044142A3 Piperazine derivatives, their preparation and their use for treating central nervous system (cns) disorders |
| 08/08/2002 | WO2002040505A3 Dibenzoxazepine alpha v integrin receptor antagonist |
| 08/08/2002 | WO2002038541A9 Cyanopyrrolidine derivatives |
| 08/08/2002 | WO2002034716A3 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 08/08/2002 | WO2002032900A3 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | WO2002030455A3 Agents for the treatment of viral infections |
| 08/08/2002 | WO2002028165A3 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 08/08/2002 | WO2002026192A3 Viruses targeted to hypoxic cells and tissues |
| 08/08/2002 | WO2002022161A3 The diagnosis, prevention, and/or treatment of atherosclerosis and underlying and/or related diseases |
| 08/08/2002 | WO2002019971A9 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 08/08/2002 | WO2002018327A3 Guanidinobenzamides as mc4-r agonists |
| 08/08/2002 | WO2002017894A3 Pharmaceutical formulation of salmeterol and fluticasone propionate |
| 08/08/2002 | WO2002014269A3 2,4-substituted pyridine derivatives |
| 08/08/2002 | WO2002011735A3 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002011665A3 Association of a purine and a nonsteroidal anti-inflammatory drug for treating sexual dysfunction |
| 08/08/2002 | WO2002010140A3 Imidazolyl derivatives |
| 08/08/2002 | WO2002009690A3 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 08/08/2002 | WO2002005801A3 Compositions containing diacyltartaric salts of (e)-metanicotine |
| 08/08/2002 | WO2002003986A3 Use of substituted indole compounds for treating breast disorders |
| 08/08/2002 | WO2002002518A3 Compounds to treat alzheimer's disease |
| 08/08/2002 | WO2002000840A3 Human lyases |
| 08/08/2002 | WO2002000631A3 Benzhydryl derivatives |
| 08/08/2002 | WO2002000170A3 Targeted delivery of cytotoxic drugs a) to activated lymphocytes in patients with transplanted organs, b) as radiosensitizers to cancer cells in patients undergoing radiation therapy, and c) in vitamin-binding proteins as drug carriers in the diagnosis and treatment of cancer |
| 08/08/2002 | WO2001098455A3 Method for preparing a physiologically active il-18 polypeptide |
| 08/08/2002 | WO2001098268A3 Piperidine amides as modulators of chemokine receptor activity |
| 08/08/2002 | WO2001097858A3 Cold anti-cd20 antibody/radiolabeled anti-cd22 antibody combination |
| 08/08/2002 | WO2001096546A3 Protein phosphatases |
| 08/08/2002 | WO2001096393A3 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 08/08/2002 | WO2001095899A3 Pharmaceutical compositions comprising cannabidiol derivatives |
| 08/08/2002 | WO2001094312A3 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | WO2001090330A3 AMINOACYL tRNA SYNTHETASES |
| 08/08/2002 | WO2001087935A3 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (pttg) |
| 08/08/2002 | WO2001085664A3 Compounds and methods for regulating bacterial growth and pathogenesis |
| 08/08/2002 | WO2001085150A3 Opioid antagonist containing composition for enchaching the potency or reducing adverse side effects ofopioid agonists |
| 08/08/2002 | WO2001082938A3 Compositions useful in the treatment of diseases of connective tissues comprising a ferrous ion and an ascorbate |
| 08/08/2002 | WO2001082918A9 Method for the prevention of apoptosis |
| 08/08/2002 | WO2001081585A3 A thymus expressed human cytochrome p450 (p450tec) |
| 08/08/2002 | WO2001081334A3 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands |
| 08/08/2002 | WO2001081312A3 Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore |
| 08/08/2002 | WO2001068077A3 Immunostimulatory polynucleotide sequences for use in preventing and treating viral infections |
| 08/08/2002 | WO2001064685A3 Thienopyridine derivatives and their use as anti-inflammatory agents |
| 08/08/2002 | WO2001056555A3 Use of cox-2 inhibitors for the treatment of constipation |
| 08/08/2002 | WO2001051641A9 Irak-4: compositions and methods of use |
| 08/08/2002 | WO2001051523A3 Anti-angiogenic proteins and fragments and methods of use thereof |
| 08/08/2002 | WO2001048238A3 Chemotherapeutant screening method |
| 08/08/2002 | WO2001036419A9 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/08/2002 | WO2001032925A9 Modulation of neuroendocrine differentiation by protein 25.1 |
| 08/08/2002 | WO2001027635A9 Multiwell scanner and scanning method |
| 08/08/2002 | WO2001016330A3 Prevention of affections associated with porcine circovirus-2 |
| 08/08/2002 | WO2001009325A9 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/08/2002 | US20020107402 Aminoaryl oxazolidinone N-oxides |
| 08/08/2002 | US20020107400 Cyanoguanidines as cell proliferation inhibitors |
| 08/08/2002 | US20020107392 Quinolinone derivatives |
| 08/08/2002 | US20020107375 Novel human lipocalin homologs and polynucleotides encoding the same |
| 08/08/2002 | US20020107370 Protein for use in the treatment of lzheimer's, parkinson's, amyotrophic lateral sclerosis, multiple sclerosis, retinopathy, brain, blood, myocardium, stroke, reperfusion injury and liver disorders |
| 08/08/2002 | US20020107363 B7-Like molecules and uses thereof |
| 08/08/2002 | US20020107359 Protein model for use in drug design in human therapeutics |
| 08/08/2002 | US20020107289 Regulation of phospholipase D activity |
| 08/08/2002 | US20020107280 Selective COX II inhibitor |
| 08/08/2002 | US20020107278 Substituted azepino[4,5b]indole derivatives |
| 08/08/2002 | US20020107276 Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene B4 receptor antagonist |
| 08/08/2002 | US20020107273 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 08/08/2002 | US20020107271 Heterocyclic aromatic oxazole compounds and use thereof |
| 08/08/2002 | US20020107270 Selective inhibitory action on cyclooxygenase- 2 and are expected to be useful as anti-inflammatory agents with less side-effects such as digestive tract disorders. |
| 08/08/2002 | US20020107264 Optionally oxygenated hydrogenated thiophenes, thiopyrans and thiomorpholines containing hydroxyethylamine groups |
| 08/08/2002 | US20020107263 Squaric acid derivatives |
| 08/08/2002 | US20020107262 Substituted imidazopyridines |
| 08/08/2002 | US20020107261 Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors |
| 08/08/2002 | US20020107255 Potent and selective inhibitors of chemokine binding to its receptor CCR1 found on inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes). |
| 08/08/2002 | US20020107254 P-substituted-N-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide, |
| 08/08/2002 | US20020107252 Novel Compounds |
| 08/08/2002 | US20020107251 4-(hetero)aryl-3-oxo-3,4-dihydropyrido(2,3-b)pyrazine derivatives; prophylactic or therapeutic treatment of phosphodiesterase IV and tumor necrosis factor mediated diseases |
| 08/08/2002 | US20020107250 Orally deliverable cyclooxygenase-2 inhibitor of low water solubility, for example celecoxib, and a glycol ether, for example diethylene glycol monoethyl ether. |
| 08/08/2002 | US20020107249 Administering a compound having a pharmacological selectivity of serotonin (Ki)/norepinephrine of at least about 5000, such as reboxetine; treating and prophylaxis of various psychological and neurological disorders |
| 08/08/2002 | US20020107244 Combination treatment for depression |